In previous report, Ogle LF et al. demonstrated in their analysis of CTCs from patients with HCC that the detection rates of AFP, GPC3, and EpCAM were 20%, 12.5%, and 18%, respectively, while 28% were negative for all.19 This evidence concerns the gene GPC3 and hepatocellular carcinoma.